Skip to main content
. 2004 May 26;90(11):2197–2202. doi: 10.1038/sj.bjc.6601832

Table 2. Univariate analysis of overall survival.

Variable P-value
EBAG9 immunoreactivity (+ vs −) 0.689
Histological type 0.0177
Histological grade 0.0085
Stage <0.0001
Residual tumour <0.0001